HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Despite survival benefits, role of IP chemotherapy remains unclear
-
- Findings may point toward new beginnings for treatment of luminal A breast cancer Adam M. Brufsky, MD, PhD
- Lung Cancer Drugs in the Pipeline
- Precision cancer care: The knowledge (and reality) gap John Sweetenham, MD, FRCP, FACP
- Empliciti approved for previously treated multiple myeloma
- FDA approves Ablatherm HIFU treatment for prostate cancer
- FDA approves cooling system for chemotherapy-associated hair loss
- FDA approves Vonvendi to treat bleeding episodes
- FDA approves Alecensa for ALK-positive NSCLC
-
- Carbon monoxide, acrolein decrease in smokers who switch to e-cigarettes
- Immediate surgery for low-risk thyroid cancer raises likelihood of unfavorable events
- Matched-sibling HSCT often successful for patients with sickle cell disease
- Obesity in early adulthood increases risk for HCC
- Radiotherapy, TKIs improve survival for patients with ALK-rearranged NSCLC, brain metastases
- Invasive breast cancer outcomes after neoadjuvant chemotherapy similar regardless of locoregional treatment
- ESR1 mutations linked to poorer OS in ER-positive breast cancer
- 6-mercaptopurine intake often over-reported during pediatric ALL maintenance therapy
-
- Anti–B-cell maturation antigen CAR T cells show promise for advanced multiple myeloma
- Gene therapy reduces transfusion dependence in patients with beta-thalassemia major
- LMWH dose-reduction guidelines appear safe, effective for chemotherapy-induced thrombocytopenia
- Researchers identify genetic osteonecrosis risk factors in pediatric ALL
- Thymidylate synthase polymorphism increases risk for bony morbidity in pediatric ALL
- Pathologic complete response to neoadjuvant chemotherapy predicts survival in triple-negative breast cancer
- T-DM1 significantly extends OS in HER-2–positive metastatic breast cancer
- Counseling increases knowledge, decreases anxiety among women undergoing comprehensive genetic screening
-